Large-scale CRISPR-Cas9 screens to define regulators of immune checkpoints

Area of Science:

• Immunology
• Genetics
• Cancer Biology

Background:

• Immune checkpoints are crucial targets for cancer treatment.
• Understanding their regulation is key for therapeutic development.
• CRISPR-Cas9 screening is a powerful tool for studying gene function.

Purpose of the Study:

• To develop a framework for CRISPR-Cas9 screens to study immune checkpoint regulators.
• To use fluorescence-activated cell sorting (FACS) for isolating and analyzing cells with specific CRISPR perturbations.
• To gain insights into immune checkpoint regulation and interactions in cancer models.

Main Methods:

• Utilized CRISPR-Cas9 screening to systematically interrogate regulators of immune checkpoints.
• Coupled CRISPR screening with fluorescence-activated cell sorting (FACS) for cell isolation and analysis.
• Applied the framework to melanoma models to study immune checkpoint dynamics.

Main Results:

• Demonstrated a reliable method for isolating and comparing the impact of CRISPR perturbations on immune checkpoint expression.
• Provided critical insights into the dynamic regulation and interactions of immune checkpoints.
• Validated the approach in melanoma models.

Conclusions:

• The developed framework offers a reliable method for studying immune checkpoint regulation using CRISPR-Cas9 and FACS.
• This approach provides valuable insights into cancer immunobiology and therapeutic targets.
• The methodology is feasible for expansion to other cancer systems and research areas.